通策医疗（600763）2月5日主力资金净买入5697.39万元

Group 1 - The core stock price of Tongce Medical (600763) closed at 50.82 yuan on February 5, 2026, with an increase of 4.05% and a turnover rate of 5.56% [1] - The total trading volume was 248,500 hands, with a transaction amount of 1.263 billion yuan [1] - The net inflow of main funds was 56.9739 million yuan, accounting for 4.51% of the total transaction amount, while retail investors had a net outflow of 80.8599 million yuan, accounting for 6.4% [1] Group 2 - In the financing and securities lending data, the financing buy amounted to 85.6864 million yuan, while the financing repayment was 122 million yuan, resulting in a net repayment of 36.5689 million yuan [2] - The securities lending sell was 4,700 shares, with a repayment of 3,900 shares, leaving a remaining amount of 212,100 shares and a balance of 10.7779 million yuan [2] - The total financing and securities lending balance was 774 million yuan [2] Group 3 - For the first three quarters of 2025, Tongce Medical reported a main revenue of 2.29 billion yuan, a year-on-year increase of 2.56%, and a net profit attributable to shareholders of 514 million yuan, up 3.16% year-on-year [3] - The gross profit margin was 41.69%, with a debt ratio of 25.1% and investment income of 41.2243 million yuan [3] - In the latest 90 days, four institutions provided ratings for the stock, with three buy ratings and one hold rating, and the average target price was 51.1 yuan [3]